Inherited Retinal Disease Global Market Report 2025

Description

Inherited retinal diseases are a group of rare genetic disorders caused by mutations in specific genes, primarily affecting the retina, the light-sensitive tissue at the back of the eye. These diseases are often challenging to treat due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising treatment options.

The main approaches for treating inherited retinal diseases include diagnosis and therapy. Diagnosis utilizes advanced technologies such as genetic testing, optical coherence tomography, and fundus imaging to identify these diseases and determine their genetic causes. These treatments address various conditions such as retinitis pigmentosa, choroideremia, Stargardt disease, cone-rod dystrophy, Leber congenital amaurosis, and others. They are distributed through channels such as retail sales and direct tenders, and are used by various end users including hospitals, specialty clinics, ambulatory surgical centers, home healthcare settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The inherited retinal disease market research report is one of a series of new reports from The Business Research Company that provides inherited retinal disease market statistics, including inherited retinal disease industry global market size, regional shares, competitors with a inherited retinal disease market share, detailed inherited retinal disease market segments, market trends and opportunities, and any further data you may need to thrive in the inherited retinal disease industry. This inherited retinal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inherited retinal disease market size has grown strongly in recent years. It will grow from $11.56 billion in 2024 to $12.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the adoption of gene therapy, regulatory incentives, growth in patient registries, rise in clinical trials, and rise in patient-centric solutions.

The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $17.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the increasing use of CRISPR, the emergence of personalized treatment, the focus on regenerative medicine, the growth in patient advocacy, and the focus on improving the quality of life for patients. Major trends in the forecast period include advancements in optogenetics technology, development of artificial retina implants, expansion of digital health platforms, integration of artificial intelligence in disease modeling, and use of artificial intelligence in planning treatment.

The forecast of 8.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of gene therapies and retinal imaging systems sourced from the Netherlands and France, thereby limiting access to sight-saving treatments and elevating ophthalmology care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of macular degeneration is expected to drive the growth of the inherited retinal disease market. Macular degeneration, an age-related eye condition that damages the macula, results in central vision loss and challenges with activities such as reading or recognizing faces. The rising incidence of macular degeneration is driven by factors such as aging populations, longer life expectancy, and lifestyle choices such as smoking and poor nutrition, which elevate the risk. Inherited retinal disease treatments target the genetic causes of retinal degeneration, offering therapies that can slow disease progression, restore lost vision, or prevent further damage to the retina. This ultimately improves visual outcomes and quality of life for those affected by age-related or inherited forms of macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society reported that 2.5 million Canadians over the age of 55 suffer from vision loss due to age-related macular degeneration (AMD). The increasing prevalence of macular degeneration is thus fueling market growth in the inherited retinal disease sector.

Companies in the inherited retinal disease market are focusing on innovative treatments, such as mutation-agnostic gene therapy, to address a broader range of genetic variations associated with these conditions. Mutation-agnostic gene therapy targets general genetic mechanisms or pathways rather than specific mutations, making it applicable to a wider variety of genetic disorders. For example, in March 2024, Nanoscope Therapeutics Inc., a U.S.-based biotechnology company, announced positive results from a clinical trial of its lead program, MCO-010, which demonstrated vision improvements for patients with severe, permanent vision loss from advanced retinitis pigmentosa. MCO-010 achieved both primary and key secondary endpoints with statistical significance and no serious adverse events.

In October 2024, Ocuphire Pharma, Inc., a U.S.-based biopharmaceutical company, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition aimed to strengthen Ocuphire Pharma's gene therapy portfolio and expedite the development of treatments for inherited retinal diseases (IRDs) by integrating Opus Genetics Inc.'s innovative gene therapies for rare retinal conditions. Opus Genetics Inc. is a clinical-stage company focused on advancing gene therapies for inherited retinal diseases.

Major players in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inherited retinal disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inherited retinal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inherited retinal disease market includes revenues earned by entities by providing services such as ophthalmic tests, optic nerve imaging, and electrophysiological tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inherited Retinal Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inherited retinal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inherited retinal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The inherited retinal disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Diagnosis; Therapy
2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases
3) By Distribution Channel: Retail Sales; Direct Tender
4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users
Subsegments:
1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy
Companies Mentioned: Johnson & Johnson; Novartis AG; Astellas Pharma Inc.; Biogen Inc.; Vertex Pharmaceuticals Inc.; Ionis Pharmaceuticals Inc.; Invitae Corporation; Spark Therapeutics; Aldeyra Therapeutics; Regenxbio Inc.; IVERIC bio; MeiraGTx Limited; Ocugen Inc.; Coave Therapeutics; Bionic Vision Technologies; GenSight Biologics SA; LKC Technologies Inc.; Sparing Vision; ProQR Therapeutics NV; Endogena Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33780u

1. Executive Summary

2. Inherited Retinal Disease Market Characteristics

3. Inherited Retinal Disease Market Trends And Strategies

4. Inherited Retinal Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Inherited Retinal Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Inherited Retinal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Inherited Retinal Disease Market Growth Rate Analysis
5.4. Global Inherited Retinal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Inherited Retinal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Inherited Retinal Disease Total Addressable Market (TAM)

6. Inherited Retinal Disease Market Segmentation

6.1. Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnosis
Therapy
6.2. Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinitis Pigmentosa
Choroideremia
Stargardt Disease
Cone-rode Dystrophy
Leber Congenital Amaurosis
Other Diseases
6.3. Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Sales
Direct Tender
6.4. Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Home Healthcare
Other End Users
6.5. Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing (Genetic Screening)
Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT))
Electrophysiological Testing (Electroretinography)
Visual Field Testing
Fundus Autofluorescence Imaging
6.6. Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Stem Cell Therapy
Retinal Prosthesis (Artificial Retina)
Pharmacological Therapy (Gene Editing, Retinal Drugs)
Photoreceptor Rescue Therapy

7. Inherited Retinal Disease Market Regional And Country Analysis

7.1. Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inherited Retinal Disease Market

8.1. Asia-Pacific Inherited Retinal Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inherited Retinal Disease Market

9.1. China Inherited Retinal Disease Market Overview
9.2. China Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inherited Retinal Disease Market

10.1. India Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inherited Retinal Disease Market

11.1. Japan Inherited Retinal Disease Market Overview
11.2. Japan Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inherited Retinal Disease Market

12.1. Australia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inherited Retinal Disease Market

13.1. Indonesia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inherited Retinal Disease Market

14.1. South Korea Inherited Retinal Disease Market Overview
14.2. South Korea Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inherited Retinal Disease Market

15.1. Western Europe Inherited Retinal Disease Market Overview
15.2. Western Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inherited Retinal Disease Market

16.1. UK Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inherited Retinal Disease Market

17.1. Germany Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inherited Retinal Disease Market

18.1. France Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inherited Retinal Disease Market

19.1. Italy Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inherited Retinal Disease Market

20.1. Spain Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inherited Retinal Disease Market

21.1. Eastern Europe Inherited Retinal Disease Market Overview
21.2. Eastern Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inherited Retinal Disease Market

22.1. Russia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inherited Retinal Disease Market

23.1. North America Inherited Retinal Disease Market Overview
23.2. North America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inherited Retinal Disease Market

24.1. USA Inherited Retinal Disease Market Overview
24.2. USA Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inherited Retinal Disease Market

25.1. Canada Inherited Retinal Disease Market Overview
25.2. Canada Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inherited Retinal Disease Market

26.1. South America Inherited Retinal Disease Market Overview
26.2. South America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inherited Retinal Disease Market

27.1. Brazil Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inherited Retinal Disease Market

28.1. Middle East Inherited Retinal Disease Market Overview
28.2. Middle East Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inherited Retinal Disease Market

29.1. Africa Inherited Retinal Disease Market Overview
29.2. Africa Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inherited Retinal Disease Market Competitive Landscape And Company Profiles

30.1. Inherited Retinal Disease Market Competitive Landscape
30.2. Inherited Retinal Disease Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Inherited Retinal Disease Market Other Major And Innovative Companies

31.1. Ionis Pharmaceuticals Inc.
31.2. Invitae Corporation
31.3. Spark Therapeutics
31.4. Aldeyra Therapeutics
31.5. Regenxbio Inc.
31.6. IVERIC bio
31.7. MeiraGTx Limited
31.8. Ocugen Inc.
31.9. Coave Therapeutics
31.10. Bionic Vision Technologies
31.11. GenSight Biologics SA
31.12. LKC Technologies Inc.
31.13. Sparing Vision
31.14. ProQR Therapeutics NV
31.15. Endogena Therapeutics

32. Global Inherited Retinal Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inherited Retinal Disease Market

34. Recent Developments In The Inherited Retinal Disease Market

35. Inherited Retinal Disease Market High Potential Countries, Segments and Strategies

35.1 Inherited Retinal Disease Market In 2029 - Countries Offering Most New Opportunities
35.2 Inherited Retinal Disease Market In 2029 - Segments Offering Most New Opportunities
35.3 Inherited Retinal Disease Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer